Ketamine in the Treatment of Major Depressive Disorder

被引：3
|
作者：
Luu, Brent [1 ]
Rice, Elizabeth [1 ]
Goldin, Philippe [1 ]
机构：
[1] Univ Calif Davis, Betty Irene Moore Sch Nursing, Sacramento, CA 95817 USA
来源：
JNP-JOURNAL FOR NURSE PRACTITIONERS | 2020年 / 16卷 / 03期
关键词：
depression; ketamine; major depressive disorder (MDD); mechanism of ketamine; psychiatric conditions; treatment of MDD; GAMMA-AMINOBUTYRIC-ACID; COMPLICATIONS; PHARMACOLOGY; INFUSIONS; GLUTAMATE; CARE;
D O I：
10.1016/j.nurpra.2019.07.016
中图分类号：
R47 [护理学];
学科分类号：
1011 ;
摘要：
Major depressive disorder (MDD) is a prevalent and highly debilitating psychiatric condition that affects many young adults worldwide. This brief review summarizes the current available data about the use of ketamine as a treatment for MDD. We describe pharmacological mechanisms, dose considerations, drug interactions, side effects, and the relevancy of ketamine in the treatment of MDD. (C) 2019 Elsevier Inc. All rights reserved.
引用
收藏
页码：228 / 231
页数：4
相关论文
共 50 条
  • [31] Neurocognitive Effects of Ketamine and Esketamine for Treatment-Resistant Major Depressive Disorder: A Systematic Review
    Souza-Marques, Breno
    Santos-Lima, Cassio
    Araujo-de-Freitas, Lucas
    Vieira, Flavia
    Jesus-Nunes, Ana Paula
    Quarantini, Lucas C.
    Sampaio, Aline S.
    [J]. HARVARD REVIEW OF PSYCHIATRY, 2021, 29 (05) : 340 - 350
  • [32] Lithium in the Treatment of Major Depressive Disorder
    Tom Bschor
    [J]. Drugs, 2014, 74 : 855 - 862
  • [33] Treatment guidelines for major depressive disorder
    Hollon, SD
    Shelton, RC
    [J]. BEHAVIOR THERAPY, 2001, 32 (02) : 235 - 258
  • [34] Amantadine: a treatment for major depressive disorder
    Ruiz-Chow, A.
    Ramirez-Bermudez, J.
    Alviso-de la Serna, L.
    Rios, C.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2010, 20 : S352 - S352
  • [35] Vortioxetine for the treatment of major depressive disorder
    Tritschler, Laurent
    Felice, Daniela
    Colle, Romain
    Guilloux, Jean-Philippe
    Corruble, Emmanuelle
    Gardier, Alain Michel
    David, Denis Joseph
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (06) : 731 - 745
  • [36] Agomelatine Treatment of Major Depressive Disorder
    Dolder, Christian R.
    Nelson, Michael
    Snider, Morgan
    [J]. ANNALS OF PHARMACOTHERAPY, 2008, 42 (12) : 1822 - 1831
  • [37] Lithium in the Treatment of Major Depressive Disorder
    Bschor, Tom
    [J]. DRUGS, 2014, 74 (08) : 855 - 862
  • [38] Desvenlafaxine in the treatment of major depressive disorder
    Lourenco, Maria Teresa C.
    Kennedy, Sidney H.
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2009, 5 : 127 - 136
  • [39] Desvenlafaxine for the treatment of major depressive disorder
    Kornstein, Susan G.
    McIntyre, Roger S.
    Thase, Michael E.
    Boucher, Matthieu
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2014, 15 (10) : 1449 - 1463
  • [40] Vortioxetine in the treatment of major depressive disorder
    Baldwin, David S.
    Hanumanthaiah, Venkatesh Ballagere
    [J]. FUTURE NEUROLOGY, 2015, 10 (02) : 79 - 89
12345